UBS AM’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
207,198
+58,918
| +40% | +$423K | ﹤0.01% | 2273 |
|
|
2025
Q1 | $888K | Buy |
148,280
+12,676
| +9% | +$75.9K | ﹤0.01% | 2360 |
|
|
2024
Q4 | $1.06M | Buy |
135,604
+17,741
| +15% | +$138K | ﹤0.01% | 2334 |
|
|
2024
Q3 | $1.27M | Sell |
117,863
-8,354
| -7% | -$90.2K | ﹤0.01% | 2273 |
|
|
2024
Q2 | $1.06M | Buy |
126,217
+56,660
| +81% | +$478K | ﹤0.01% | 2344 |
|
|
2024
Q1 | $467K | Buy |
69,557
+10,000
| +17% | +$67.2K | ﹤0.01% | 2307 |
|
|
2023
Q4 | $350K | Buy |
59,557
+7,900
| +15% | +$46.5K | ﹤0.01% | 2393 |
|
|
2023
Q3 | $504K | Buy |
51,657
+29,457
| +133% | +$287K | ﹤0.01% | 2296 |
|
|
2023
Q2 | $240K | Hold |
22,200
| – | – | ﹤0.01% | 2532 |
|
|
2023
Q1 | $240K | Hold |
22,200
| – | – | ﹤0.01% | 2532 |
|
|
2022
Q4 | $257K | Buy |
+22,200
| New | +$257K | ﹤0.01% | 2374 |
|